ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.411,55
-0,27%
S&P 500
5.321,41
0,25%
US Dollar vs BRL
5,1233
0,00%
Bitcoin
69.778,59
-0,50%
Brent Oil
82,25
-0,24%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Momenta Pharmaceuticals Inc (MNTA)

  7. Momenta Pharmaceuticals Inc (MNTA) Notícias

MNTA

Momenta Pharmaceuticals (MNTA)

Momenta Pharmaceuticals Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:MNTA
DataHoraFonteTítuloCódigoCompanhia
10/11/202012:28Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MNTAMomenta Pharmaceuticals Inc
13/10/202009:15Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:MNTAMomenta Pharmaceuticals Inc
01/10/202018:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MNTAMomenta Pharmaceuticals Inc
01/10/202017:55Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:MNTAMomenta Pharmaceuticals Inc
01/10/202017:31Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:MNTAMomenta Pharmaceuticals Inc
01/10/202017:21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MNTAMomenta Pharmaceuticals Inc
01/10/202010:55Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:MNTAMomenta Pharmaceuticals Inc
01/10/202010:00Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:MNTAMomenta Pharmaceuticals Inc
01/10/202009:57Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:MNTAMomenta Pharmaceuticals Inc
01/10/202009:44GlobeNewswire Inc.Momenta Pharmaceuticals Announces Completion of Proposed Sale to Johnson & JohnsonNASDAQ:MNTAMomenta Pharmaceuticals Inc
25/09/202018:47PR Newswire (US)Chesapeake Utilities to Join S&P SmallCap 600NASDAQ:MNTAMomenta Pharmaceuticals Inc
15/09/202009:00GlobeNewswire Inc.Momenta Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period in Connection with Proposed Sale to Johnson ...NASDAQ:MNTAMomenta Pharmaceuticals Inc
02/09/202007:54Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:MNTAMomenta Pharmaceuticals Inc
20/08/202016:18Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:MNTAMomenta Pharmaceuticals Inc
20/08/202004:02Dow Jones NewsJ&J, Biotech Firm In $6.5 Billion Deal J&J Agrees to Buy Biotech Company -- WSJNASDAQ:MNTAMomenta Pharmaceuticals Inc
19/08/202017:26Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:MNTAMomenta Pharmaceuticals Inc
19/08/202008:21Dow Jones NewsJohnson & Johnson to Buy Momenta Pharmaceuticals for $6.5 BillionNASDAQ:MNTAMomenta Pharmaceuticals Inc
19/08/202007:35GlobeNewswire Inc.Momenta Enters Definitive Agreement with Johnson & JohnsonNASDAQ:MNTAMomenta Pharmaceuticals Inc
10/08/202017:44Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MNTAMomenta Pharmaceuticals Inc
10/08/202008:00GlobeNewswire Inc.Momenta Pharmaceuticals Reports Second Quarter 2020 Financial and Operating ResultsNASDAQ:MNTAMomenta Pharmaceuticals Inc
03/08/202008:30GlobeNewswire Inc.Momenta Pharmaceuticals Announces Date of Second Quarter 2020 Financial Results Conference Call and WebcastNASDAQ:MNTAMomenta Pharmaceuticals Inc
28/07/202008:15GlobeNewswire Inc.Momenta Pharmaceuticals Announces FDA Rare Pediatric Disease Designation for Nipocalimab in HDFNNASDAQ:MNTAMomenta Pharmaceuticals Inc
15/06/202008:05GlobeNewswire Inc.Momenta Pharmaceuticals Announces Positive Topline Data from Interim Analysis of Phase 2 Vivacity-MG Study of Nipocalimab (M2...NASDAQ:MNTAMomenta Pharmaceuticals Inc
07/05/202008:00GlobeNewswire Inc.Momenta Pharmaceuticals Reports First Quarter 2020 Financial and Operating ResultsNASDAQ:MNTAMomenta Pharmaceuticals Inc
06/05/202011:04Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:MNTAMomenta Pharmaceuticals Inc
24/04/202018:29Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:MNTAMomenta Pharmaceuticals Inc
23/04/202009:00GlobeNewswire Inc.Momenta Pharmaceuticals Announces Date of First Quarter 2020 Financial Results Conference Call and WebcastNASDAQ:MNTAMomenta Pharmaceuticals Inc
02/04/202008:30GlobeNewswire Inc.Momenta Provides Corporate Update Amid COVID-19 PandemicNASDAQ:MNTAMomenta Pharmaceuticals Inc
27/02/202018:35Edgar (US Regulatory)Annual Report (10-k)NASDAQ:MNTAMomenta Pharmaceuticals Inc
26/02/202009:00GlobeNewswire Inc.Momenta Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial ResultsNASDAQ:MNTAMomenta Pharmaceuticals Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:MNTA

Seu Histórico Recente

BIT
XZME
Xtrackers Msci Usa Esg U...
EU
ALICR
ICeram
COIN
ERSDLUSD
UnFederalReserveToken
ASX
SPKSO2
BIT
UV4L2M
UniCredit Bank
LATK
BLOKUSDT
BLOK
NASDAQ
AAZBSXX
Hsbc Usa Inc Capped Dual...
BIT
SL5TIT
Societe Generale Effekten
NASDAQ
FPBNVX
Diversified Equity Strat...
ASX
IFLN
LSE
DTYB
Dignity
TSX
BTO
B2Gold
LBNK
FASTUSDT
PodFast
BIT
S30602
Societe Generale Effekten
NASDAQ
RGRLX
RBC Global Equity Leader...
BIT
UB3ZEB
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados